Issue

Vol. 12 (2020)

Self-Assembly Protein Superstructures as a Powerful Chemodynamic Therapy Nanoagent for Glioblastoma Treatment

https://doi.org/10.1007/s40820-020-00490-6
Tao Zheng
Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark
Wentao Wang
Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark
Jon Ashley
Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark
Ming Zhang
Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark
Xiaotong Feng
Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark
Jian Shen
Jiangsu Collaborative Innovation Center for Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing 210023, People’s Republic of China
Yi Sun
Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark

Corresponding Author: Yi Sun

suyi@dtu.dk

Nano-Micro Letters, Vol. 12 (2020), Article Number: 151

Abstract

Glioblastoma (GBM) remains a formidable challenge in oncology. Chemodynamic therapy (CDT) that triggers tumor cell death by reactive oxygen species (ROS) could open up a new door for GBM treatment. Herein, we report a novel CDT nanoagent. Hemoglobin (Hb) and glucose oxidase (GOx) were employed as powerful CDT catalysts. Instead of encapsulating the proteins in drug delivery nanocarriers, we formulate multimeric superstructures as self-delivery entities by crosslinking techniques. Red blood cell (RBC) membranes are camouflaged on the protein superstructures to promote the delivery across blood–brain barrier. The as-prepared RBC@Hb@GOx nanoparticles (NPs) offer superior biocompatibility, simplified structure, and high accumulation at the tumor site. We successfully demonstrated that the NPs could efficiently produce toxic ROS to kill U87MG cancer cells in vitro and inhibit the growth of GBM tumor in vivo, suggesting that the new CDT nanoagent holds great promise for treating GBM.


Highlights:


1 A new type of protein nanostructure as a chemodynamic therapy nanoagent was fabricated via proper assembling and crosslinking techniques.
2 The as-fabricated nanostructures could cross the blood–brain barrier, possessing excellent long circulating times and accumulation properties at the tumor site.
3 The RBC@Hb@GOx NPs can be regarded as ‘pure particles of drugs,’ which can produce toxic reactive oxygen species to inhibit the growth of orthotopic brain tumor.








Keywords

Self-assembly protein superstructures Glioblastoma therapy Chemodynamic therapy Self-delivery entities Blood–brain barrier
Zheng, Tao, Wentao Wang, Jon Ashley, Ming Zhang, Xiaotong Feng, Jian Shen, and Yi Sun. 2020. “Self-Assembly Protein Superstructures As a Powerful Chemodynamic Therapy Nanoagent for Glioblastoma Treatment”. Nano-Micro Letters 12 (July):151. https://doi.org/10.1007/s40820-020-00490-6.
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. N.G. Rainov, C.M. Kramm, U. Banning, D. Riemann, H.J. Holzhausen et al., Immune response induced by retrovirus-mediated HSV-Tk/GCV pharmacogene therapy in patients with glioblastoma multiforme. Gene Ther. 7(21), 1853–1858 (2000). https://doi.org/10.1038/sj.gt.3301311
  2. K. Koc, I. Anik, B. Cabuk, S. Ceylan, Fluorescein sodium-guided surgery in glioblastoma multiforme: a prospective evaluation. Br. J. Neurosurg. 22(1), 99–103 (2008). https://doi.org/10.1080/02688690701765524
  3. P. Zhang, J. Miska, C. Lee-Chang, A. Rashidi, W.K. Panek et al., Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma. Proc. Natl. Acad. Sci. U. S. A. 116(47), 23714–23723 (2019). https://doi.org/10.1073/pnas.1906346116
  4. P. Kadiyala, D. Li, F.M. Nunez, D. Altshuler, R. Doherty et al., High-density lipoprotein-mimicking nanodiscs for chemo-immunotherapy against glioblastoma multiforme. ACS Nano 13(2), 1365–1384 (2019). https://doi.org/10.1021/acsnano.8b06842
  5. M. Ji, D.A. Orringer, C.W. Freudiger, S. Ramkissoon, X. Liu et al., Rapid, label-free detection of brain tumors with stimulated raman scattering microscopy. Sci. Transl. Med. 5(201), 201ra119 (2013). https://doi.org/10.1126/scitranslmed.3005954
  6. A. Eramo, L. Ricci-Vitiani, A. Zeuner, R. Pallini, F. Lotti et al., Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ. 13(7), 1238–1241 (2006). https://doi.org/10.1038/sj.cdd.4401872
  7. N.F. Brown, T.J. Carter, D. Ottaviani, P. Mulholland, Harnessing the immune system in glioblastoma. Br. J. Cancer 119(10), 1171–1181 (2018). https://doi.org/10.1038/s41416-018-0258-8
  8. M. Zhao, D. van Straten, M.L.D. Broekman, V. Préat, R.M. Schiffelers, Nanocarrier-based drug combination therapy for glioblastoma. Theranostics 10(3), 1355–1372 (2020). https://doi.org/10.7150/thno.38147
  9. M. Huo, L. Wang, Y. Chen, J. Shi, Tumor-selective catalytic nanomedicine by nanocatalyst delivery. Nat. Commun. 8(1), 357 (2017). https://doi.org/10.1038/s41467-017-00424-8
  10. L. Feng, R. Xie, C. Wang, S. Gai, F. He, D. Yang, P. Yang, J. Lin, Magnetic targeting, tumor microenvironment-responsive intelligent nanocatalysts for enhanced tumor ablation. ACS Nano 12(11), 11000–11012 (2018). https://doi.org/10.1021/acsnano.8b05042
  11. M. Li, J. Xia, R. Tian, J. Wang, J. Fan et al., Near-infrared light-initiated molecular superoxide radical generator: rejuvenating photodynamic therapy against hypoxic tumors. J. Am. Chem. Soc. 140(44), 14851–14859 (2018). https://doi.org/10.1021/jacs.8b08658
  12. D.W. Zheng, Q. Lei, J.Y. Zhu, J.X. Fan, C.X. Li et al., Switching apoptosis to ferroptosis: metal-organic network for high-efficiency anticancer therapy. Nano Lett. 17(1), 284–291 (2017). https://doi.org/10.1021/acs.nanolett.6b04060
  13. T.L. Whiteside, The tumor microenvironment and its role in promoting tumor growth. Oncogene 27(45), 5904–5912 (2008). https://doi.org/10.1038/onc.2008.271
  14. A. Kumar, A. Tan, J. Wong, J.C. Spagnoli, J. Lam et al., Nanotechnology for neuroscience: promising approaches for diagnostics, therapeutics and brain activity mapping. Adv. Funct. Mater. 27(39), 1700489 (2017). https://doi.org/10.1002/adfm.201700489
  15. Z. Tang, Y. Liu, M. He, W. Bu, Chemodynamic therapy: tumour microenvironment-mediated fenton and fenton-like reactions. Angew. Chem. Int. Ed. 58(4), 946–956 (2019). https://doi.org/10.1002/anie.201805664
  16. P. Xue, R. Yang, L. Sun, Q. Li, L. Zhang, Z. Xu, Y. Kang, Indocyanine green-conjugated magnetic prussian blue nanoparticles for synchronous photothermal/photodynamic tumor therapy. Nano-Micro Lett. 10, 74 (2018). https://doi.org/10.1007/s40820-018-0227-z
  17. T. Wang, H. Zhang, H. Liu, Q. Yuan, F. Ren et al., Boosting H2O2-guided chemodynamic therapy of cancer by enhancing reaction kinetics through versatile biomimetic fenton nanocatalysts and the second near-infrared light irradiation. Adv. Funct. Mater. 30(3), 1906128 (2019). https://doi.org/10.1002/adfm.201906128
  18. B. Song, Y.L. Zhang, J. Liu, X.L. Feng, T. Zhou, L.Q. Shao, Is neurotoxicity of metallic nanoparticles the cascades of oxidative stress? Nanoscale Res. Lett. 11(1), 291 (2016). https://doi.org/10.1186/s11671-016-1508-4
  19. D. Duan, H. Liu, M. Xu, M. Chen, Y. Han, Y. Shi, Z. Liu, Size-controlled synthesis of drug-loaded zeolitic imidazolate framework in aqueous solution and size effect on their cancer theranostics in vivo. ACS Appl. Mater. Interfaces. 10(49), 42165–42174 (2018). https://doi.org/10.1021/acsami.8b17660
  20. X. Wu, H. Yue, Y. Zhang, X. Gao, X. Li et al., Packaging and delivering enzymes by amorphous metal-organic frameworks. Nat. Commun. 10(1), 5165 (2019). https://doi.org/10.1038/s41467-019-13153-x
  21. C.Y. Sun, Y. Liu, J.Z. Du, Z.T. Cao, C.F. Xu, J. Wang, Facile generation of tumor-PH-labile linkage-bridged block copolymers for chemotherapeutic delivery. Angew. Chem. Int. Ed. 55(3), 1010–1014 (2016). https://doi.org/10.1002/anie.201509507
  22. D. Niu, Y. Li, J. Shi, Silica/organosilica cross-linked block copolymer micelles: a versatile theranostic platform. Chem. Soc. Rev. 46(3), 569–585 (2017). https://doi.org/10.1039/c6cs00495d
  23. C. Maiti, S. Parida, S. Kayal, S. Maiti, M. Mandal, D. Dhara, Redox-responsive core-cross-linked block copolymer micelles for overcoming multidrug resistance in cancer cells. ACS Appl. Mater. Interfaces. 10(6), 5318–5330 (2018). https://doi.org/10.1021/acsami.7b18245
  24. D. Shen, J. Yang, X. Li, L. Zhou, R. Zhang et al., Biphase stratification approach to three-dimensional dendritic biodegradable mesoporous silica nanospheres. Nano Lett. 14(2), 923–932 (2014). https://doi.org/10.1021/nl404316v
  25. T.L. Nguyen, Y. Choi, J. Kim, Mesoporous silica as a versatile platform for cancer immunotherapy. Adv. Mater. 31(4), 1803953 (2019). https://doi.org/10.1002/adma.201803953
  26. S.I. Ahn, Y.J. Sei, H.J. Park, J. Kim, Y. Ryu et al., Microengineered human blood–Brain barrier platform for understanding nanoparticle transport mechanisms. Nat. Commun. 11(1), 175 (2020). https://doi.org/10.1038/s41467-019-13896-7
  27. C.B. Liu, J.Q. Chen, Y. Zhu, X.J. Gong, R.Q. Zheng et al., Highly sensitive MoS2–indocyanine green hybrid for photoacoustic imaging of orthotopic brain glioma at deep site. Nano-Micro Lett. 10, 48 (2018). https://doi.org/10.1007/s40820-018-0202-8
  28. T. Miao, X. Ju, Q. Zhu, Y. Wang, Q. Guo, T. Sun, C. Lu, L. Han, Nanoparticles surmounting blood–brain tumor barrier through both transcellular and paracellular pathways to target brain metastases. Adv. Funct. Mater. 29(27), 1900259 (2019). https://doi.org/10.1002/adfm.201900259
  29. C. Fillebeen, L. Descamps, M.P. Dehouck, L. Fenart, M. Benaïssa, G. Spik, R. Cecchelli, A. Pierce, A receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J. Biol. Chem. 274(11), 7011–7017 (1999). https://doi.org/10.1074/jbc.274.11.7011
  30. X. Liu, Z. Shen, J. Jiang, H. Meng, Transcytosis—an effective targeting strategy that is complementary to “EPR effect” for pancreatic cancer nano drug delivery. Theranostics 9(26), 8018–8025 (2019). https://doi.org/10.7150/thno.38587
  31. J. Trojan, T. R. Johnson, S. D. Rudin, J. Ilan, Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science 259, 94–97 (1993). https://doi.org/10.1126/science.8418502
  32. F. Ahmad, Q. Sun, D. Patel, J.M. Stommel, Cholesterol metabolism: a potential therapeutic target in glioblastoma. Cancers 11(2), 146 (2019). https://doi.org/10.3390/cancers11020146
  33. J. Feng, S. Lepetre-Mouelhi, A. Gautier, S. Mura, C. Cailleau et al., A new painkiller nanomedicine to bypass the blood-brain barrier and the use of morphine. Sci. Adv. 5(2), eaau5148 (2019). https://doi.org/10.1126/sciadv.aau5148
  34. V.V. Bamm, M.E.L. Henein, S.L.J. Sproul, D.K. Lanthier, G. Harauz, Potential role of ferric hemoglobin in MS pathogenesis: effects of oxidative stress and extracellular methemoglobin or Its degradation products on myelin components. Free Radic. Biol. Med. 112, 494–503 (2017). https://doi.org/10.1016/j.freeradbiomed.2017.08.022
  35. H. Fini, K. Kerman, Revisiting the nitrite reductase activity of hemoglobin with differential pulse voltammetry. Anal. Chim. Acta 1104, 38–46 (2020). https://doi.org/10.1016/j.aca.2019.12.071
  36. F. Ryan, J.G. Zarruk, L. Lößlein, S. David, Ceruloplasmin plays a neuroprotective role in cerebral ischemia. Front. Neurosci. 13, 1–15 (2019). https://doi.org/10.3389/fnins.2018.00988
  37. S. Yu, Z. Chen, X. Zeng, X. Chen, Z. Gu, Advances in nanomedicine for cancer starvation therapy. Theranostics 9(26), 8026–8047 (2019). https://doi.org/10.7150/thno.38261
  38. Z. Ren, S. Sun, R. Sun, G. Cui, L. Hong et al., A metal–polyphenol-coordinated nanomedicine for synergistic cascade cancer chemotherapy and chemodynamic therapy. Adv. Mater. 32(6), 1906024 (2019). https://doi.org/10.1002/adma.201906024
  39. C.M.J. Hu, L. Zhang, S. Aryal, C. Cheung, R.H. Fang, L. Zhang, Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl. Acad. Sci. U.S.A. 108(27), 10980–10985 (2011). https://doi.org/10.1073/pnas.1106634108
  40. B.T. Luk, C.M. Jack Hu, R.H. Fang, D. Dehaini, C. Carpenter, W. Gao, L. Zhang, Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale 6(5), 2730–2737 (2014). https://doi.org/10.1039/c3nr06371b
  41. M.T. Ngo, B.A.C. Harley, Perivascular signals alter global gene expression profile of glioblastoma and response to temozolomide in a gelatin hydrogel. Biomaterials 198, 122–134 (2019). https://doi.org/10.1016/j.biomaterials.2018.06.013
  42. T. Lin, P. Zhao, Y. Jiang, Y. Tang, H. Jin et al., Blood-brain-barrier-penetrating albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways for antiglioma therapy. ACS Nano 10(11), 9999–10012 (2016). https://doi.org/10.1021/acsnano.6b04268
  43. M.S. Mathew, K. Vinod, P.S. Jayaram, R.S. Jayasree, K. Joseph, Improved bioavailability of curcumin in gliadin-protected gold quantum cluster for targeted delivery. ACS Omega 4(10), 14169–14178 (2019). https://doi.org/10.1021/acsomega.9b00917
  44. S. Liu, Z. Dai, H. Chen, H. Ju, Immobilization of hemoglobin on zirconium dioxide nanoparticles for preparation of a novel hydrogen peroxide. Biosens. Bioelectron. 19(9), 963–969 (2004). https://doi.org/10.1016/j.bios.2003.08.025
  45. J.M. Rifkind, J.G. Mohanty, E. Nagababu, The Pathophysiology of extracellular hemoglobin associated with enhanced oxidative reactions. Front. Physiol. 6, 1–7 (2015). https://doi.org/10.3389/fphys.2014.00500
  46. S.M.H. Sadrzadeh, E. Graf, S.S. Panter, P.E. Hallaway, J.W. Eaton, Hemoglobin: a biologic fenton reagent. J. Biol. Chem. 259(23), 14354–14356 (1984)
  47. T. Zheng, T. Zhou, X. Feng, J. Shen, M. Zhang, Y. Sun, Enhanced plasmon-induced resonance energy transfer (PIRET)-mediated photothermal and photodynamic therapy guided by photoacoustic and magnetic resonance imaging. ACS Appl. Mater. Interfaces. 11(35), 31615–31626 (2019). https://doi.org/10.1021/acsami.9b09296
  48. P. Zhao, Z. Tang, X. Chen, Z. He, X. He et al., Ferrous-cysteine-phosphotungstate nanoagent with neutral pH fenton reaction activity for enhanced cancer chemodynamic therapy. Mater. Horizons 6, 369–374 (2019). https://doi.org/10.1039/C8MH01176A
  49. D. Wang, H. Wu, S.Z.F. Phua, G. Yang, W. Qi Lim et al., Self-assembled single-atom nanozyme for enhanced photodynamic therapy treatment of tumor. Nat. Commun. 11(1), 357 (2020). https://doi.org/10.1038/s41467-019-14199-7
  50. Q. Wu, Z. He, X. Wang, Q. Zhang, Q. Wei et al., Cascade enzymes within self-assembled hybrid nanogel mimicked neutrophil lysosomes for singlet oxygen elevated cancer therapy. Nat. Commun. 10(1), 240 (2019). https://doi.org/10.1038/s41467-018-08234-2
  51. T. Zheng, W. Wang, F. Wu, M. Zhang, J. Shen, Y. Sun, Zwitterionic polymer-gated Au@TiO2 core-shell nanoparticles for imaging-guided combined cancer therapy. Theranostics 9(17), 5035–5048 (2019). https://doi.org/10.7150/thno.35418
  52. N.S. Goud, S.M. Ghouse, J. Vishnu, D. Komal, V. Talla et al., Synthesis of 1-benzyl-1H-benzimidazoles as galectin-1 mediated anticancer agents. Bioorg. Chem. 89, 103016 (2019). https://doi.org/10.1016/j.bioorg.2019.103016
  53. W. Zhang, X. Hu, Q. Shen, D. Xing, Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy. Nat. Commun. 10(1), 1704 (2019). https://doi.org/10.1038/s41467-019-09566-3
  54. Q. Chen, L. Liu, Y. Lu, X. Chen, Y. Zhang et al., Tumor microenvironment-triggered aggregated magnetic nanoparticles for reinforced image-guided immunogenic chemotherapy. Adv. Sci. 6(6), 1802134 (2019). https://doi.org/10.1002/advs.201802134
Read More
Author biographies are not available.
Download this PDF file
PDF SUPPLEMENTARY MATERIAL
Statistic
Read Counter : 6291 Download : 4765

Most read articles by the same author(s)